Twist Bioscience Corp (TWST): Gross Profit
$191.00M
Year ended 2025-09-30
$224.38M
Trailing 12 months to 2026-06-30
+31.4%
3-year compound annual growth
+46.1%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $191.00M | +43.2% | 2025-11-17, From 2024-10-01 |
| 2024-09-30 | $133.35M | +48.6% | 2025-11-17, From 2023-10-01 |
| 2023-09-30 | $89.73M | +6.5% | 2025-11-17, From 2022-10-01 |
| 2022-09-30 | $84.23M | +62.9% | 2024-11-18, From 2021-10-01 |
| 2021-09-30 | $51.71M | +80.2% | 2023-11-21, From 2020-10-01 |
| 2020-09-30 | $28.69M | +312.3% | 2023-06-05, From 2019-10-01 |
| 2019-09-30 | $6.96M | n/m | 2021-11-23, From 2018-10-01 |
| 2018-09-30 | -$6.76M | n/m | 2020-11-27, From 2017-10-01 |
| 2017-09-30 | -$13.25M | n/a | 2019-12-13, From 2016-10-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | 2025-09-30 | $191.00M | +43.2% |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $292.76M | +33.3% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $205.62M | +92.4% |
| Vericel Corp (VCEL) | 2025-12-31 | $205.60M | +19.5% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $90.32M | +27.5% |
| Repligen Corp (RGEN) | 2025-12-31 | $386.25M | +40.6% |
| REGENXBIO Inc. (RGNX) | 2024-12-31 | $49.76M | -6.2% |
| Novavax Inc (NVAX) | 2025-12-31 | $1.05B | +119.1% |
| Bio-Techne Corp (TECH) | 2026-06-30 | $799.07M | +1.1% |
Compare TWST, ADMA, ADPT, VCEL side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗